Drs. Peter Richardson and George Wan of Mallinckrodt Pharmaceuticals discussed new data on terlipressin for HRS-AKI. A >30% reduction in serum creatinine inpatients with hepatorenal syndrome treated with terlipressin. There have been advancements in knowledge regarding mitigation of poor outcomes in hepatorenal syndrome. However, ... Patients with decompensated cirrhosis and ascites may develop type 1 hepatorenal syndrome (HRS-1), characterized by ... Hepatorenal syndrome type 1 (HRS-1) is a severe form of acute kidney injury experienced by people with cirrhosis. The ... Patients with cirrhosis may develop hepatorenal syndrome type 1 (HRS-1), a severe but reversible acute kidney injury. ...